glp-1 suicidal ideation Association of glucagon-like peptide-1 receptor agonists with and self-injury in individuals with diabetes and obesity: a propensity-weighted, population-based cohort study | Diabetologia Exploration of the potential association

Enrolled patients have been randomized to one of four weekly treatment arms: VK2735 7.5 mg, 12.5 mg, 17.5 mg, and placebo, a slight amendment from the phase 2 doses, but allowing a higher dose to be examined under a steadier dosing titre than is administered in the phase 2 trial

doi:10.1111/j.1749-6632.1993.tb19690.x

115, E1896E1905

The Case for Glutathione You might choose glutathione if you want a "top-down" approach

In addition to lowering blood glucose levels to help treat type 2 diabetes, GLP-1 agonists also result in weight loss and other metabolic health benefits

A botanical scalp-care base used to refresh the scalp and support a clean, revitalised feel